Impact Vector: Health
## Short Segments Shingles vaccine linked to a 24% lower dementia risk. A new study reveals that older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years. This finding comes from a study involving more than 500,000 people, suggesting that for every 17 people vaccinated, one case of dementia could be prevented. The herpes zoster virus, which causes shingles, lies dormant in the nervous system and can reactivate later in life. Previous research has shown that shingles can increase the risk of cognitive decline, including dementia, by about 20%. This new evidence highlights the potential of the shingles vaccine not only to prevent painful rashes but also to reduce the risk of dementia, offering a dual benefit for older adults. At least 25% of former NFL players who died between 2016 and 2021 had CTE, a study finds. Chronic traumatic encephalopathy, or CTE, is a degenerative brain disease linked to repeated head impacts. A recent study from Mass General Brigham found that out of 878 former NFL players who died during this period, 235 donated their brains, and 215 of those were found to have CTE. This rate is significantly higher than in the general population. The findings underscore the ongoing concerns about the long-term effects of playing professional football and the need for continued efforts to make the game safer. Depression may shut down the brain’s ability to make new neurons. A major study has found that adults with depression show disrupted production of new neurons in the hippocampus, a brain region crucial for memory and learning. This disruption could weaken the brain’s ability to separate new experiences from painful memories. Researchers at Columbia University identified broad molecular changes associated with this process, which could pave the way for new treatments tailored to different biological forms of depression. These findings provide a deeper understanding of how depression affects the brain and highlight the importance of neurogenesis in mental health. Kids with brain injuries thrive at a Pennsylvania camp, but federal research funding is in flux. Camp Cranium, a week-long summer camp, provides a supportive environment for children who have survived brain injuries. However, recent decisions by Congress have put the future of federal funding for brain injury research and related grants in jeopardy. This uncertainty threatens the progress made in helping these children and underscores the need for stable funding to continue supporting innovative programs like Camp Cranium that make a significant difference in the lives of young survivors. People who live past 110 have an unusual abundance of killer immune cells. Research shows that supercentenarians, those who live to 110 and beyond, possess large numbers of rare CD4 cytotoxic T cells. These cells are capable of killing abnormal cells, including those that cause cancer. As people age, these immune cells become more common and often expand into large groups, suggesting a robust immune response to persistent threats. This discovery offers insights into the immune system's role in exceptional longevity and could inform future research on aging and disease prevention. ## Feature Story Supercharged “natural killer” cells could be a powerful new cancer weapon. Researchers have developed a method to enhance natural killer cells, enabling them to penetrate solid tumors and continue fighting cancer cells once inside. In studies conducted on mice, these specially prepared tissue-resident cells slowed the growth of several types of tumors, including melanoma and head and neck cancers. The effectiveness of these cells was further amplified when combined with the antibody drug cetuximab. This breakthrough addresses a significant challenge in cancer treatment, as traditional immune cell therapies have been more successful against blood cancers than solid tumors. Solid tumors often act as fortified strongholds, secreting signals that inhibit immune cells. By supercharging natural killer cells, scientists hope to overcome these barriers and offer a potent off-the-shelf cancer therapy. The implications of this research are profound, as it could lead to more effective treatments for solid tumors, which have historically been difficult to target. As the research progresses, the focus will be on refining these techniques and conducting clinical trials to assess their safety and efficacy in humans. If successful, this approach could revolutionize cancer treatment, providing new hope for patients with solid tumors and expanding the arsenal of tools available to oncologists.
116 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de Impact Vector: Health community!